Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment.

[1]  D. Newman,et al.  Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation , 2015, mBio.

[2]  O. Augusto,et al.  Effects of hyperbaric oxygen on Pseudomonas aeruginosa susceptibility to imipenem and macrophages. , 2015, Future microbiology.

[3]  C. Guo,et al.  Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria. , 2015, Cell metabolism.

[4]  T. Scheike,et al.  Polymorphonuclear Leukocytes Restrict Growth of Pseudomonas aeruginosa in the Lungs of Cystic Fibrosis Patients , 2014, Infection and Immunity.

[5]  C. Hansen,et al.  Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen , 2014, Clinical and experimental immunology.

[6]  Ahmad S Khalil,et al.  Antibiotics induce redox-related physiological alterations as part of their lethality. , 2014, Proceedings of the National Academy of Sciences of the United States of America.

[7]  N. Høiby,et al.  Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms. , 2014, Pathogens and disease.

[8]  N. Høiby,et al.  Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation. , 2014, International journal of antimicrobial agents.

[9]  A. Kharazmi,et al.  Nitrous Oxide Production in Sputum from Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Lung Infection , 2014, PloS one.

[10]  Thomas Bjarnsholt,et al.  Applying insights from biofilm biology to drug development — can a new approach be developed? , 2013, Nature Reviews Drug Discovery.

[11]  N. Høiby,et al.  Pseudomonas aeruginosa biofilms in cystic fibrosis. , 2010, Future microbiology.

[12]  A. Kharazmi,et al.  Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis , 2009, Thorax.

[13]  G. Uzun,et al.  Hyperbaric oxygen therapy as an anti-infective agent , 2009, Expert review of anti-infective therapy.

[14]  J. Collins,et al.  A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.

[15]  C. Harwood,et al.  Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration , 2007, Molecular microbiology.

[16]  J. Buer,et al.  Long-Term Anaerobic Survival of the Opportunistic Pathogen Pseudomonas aeruginosa via Pyruvate Fermentation , 2004, Journal of bacteriology.

[17]  Philip S. Stewart,et al.  Contributions of Antibiotic Penetration, Oxygen Limitation, and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxacin and Tobramycin , 2003, Antimicrobial Agents and Chemotherapy.

[18]  Richard C Boucher,et al.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.

[19]  D. Allison,et al.  Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. , 1991, The Journal of antimicrobial chemotherapy.

[20]  L. M. Pakman.  Inhibition of Pseudomonas aeruginosa by Hyperbaric Oxygen I. Sulfonamide Activity Enhancement and Reversal , 1971, Infection and immunity.